The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (ob/gyns) medical offices, and fertility clinics. In addition, the company offers carrier preimplantation genetic screening, preimplantation genetic diagnosis, and screening used in IVF process; micro pipettes; IVF medical devices and systems; and PARAGARD, a contraceptive option. It markets its products under Biofinity, clarity 1day, MyDay, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California.
Industry, Sector and Symbol
Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
SectorMedical
Phone925-460-3600
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.53 billion
Profitability
Miscellaneous
Employees12,000
Next Earnings Date6/6/2019 (Estimated)
OptionableOptionable
Cooper Companies (NYSE:COO) Frequently Asked Questions
What is Cooper Companies' stock symbol?
Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."
How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?
Cooper Companies declared a semiannual dividend on Tuesday, January 8th. Investors of record on Tuesday, January 22nd will be paid a dividend of $0.03 per share on Friday, February 8th. This represents a yield of 0.02%. The ex-dividend date is Friday, January 18th. View Cooper Companies' Dividend History.
How were Cooper Companies' earnings last quarter?
Cooper Companies Inc (NYSE:COO) posted its earnings results on Tuesday, March, 5th. The medical device company reported $2.88 EPS for the quarter, topping the consensus estimate of $2.50 by $0.38. The medical device company earned $628.10 million during the quarter, compared to analysts' expectations of $618.50 million. Cooper Companies had a return on equity of 17.56% and a net margin of 14.22%. View Cooper Companies' Earnings History.
When is Cooper Companies' next earnings date?
What guidance has Cooper Companies issued on next quarter's earnings?
Cooper Companies updated its FY 2019 earnings guidance on Tuesday, March, 5th. The company provided earnings per share guidance of $11.85-12.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $11.57. The company issued revenue guidance of $2.631-2.676 billion, compared to the consensus revenue estimate of $2.64 billion.
What price target have analysts set for COO?
10 Wall Street analysts have issued 12-month price targets for Cooper Companies' stock. Their predictions range from $221.00 to $330.00. On average, they expect Cooper Companies' share price to reach $306.8889 in the next year. This suggests a possible upside of 7.0% from the stock's current price. View Analyst Price Targets for Cooper Companies.
What is the consensus analysts' recommendation for Cooper Companies?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 1 sell rating, 1 hold rating and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cooper Companies.
Has Cooper Companies been receiving favorable news coverage?
News stories about COO stock have trended positive this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cooper Companies earned a coverage optimism score of 2.7 on InfoTrie's scale. They also assigned press coverage about the medical device company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future.
Who are some of Cooper Companies' key competitors?
Some companies that are related to Cooper Companies include Shire (SHPG), Express Scripts (ESRX), Boston Scientific (BSX), Zoetis (ZTS), Allergan (AGN), Illumina (ILMN), Biogen (BIIB), Vertex Pharmaceuticals (VRTX), Shire (SHP), Merck KGaA (MRK), HCA Healthcare (HCA), Baxter International (BAX), Siemens Healthineers (SHL), Regeneron Pharmaceuticals (REGN) and Edwards Lifesciences (EW).
What other stocks do shareholders of Cooper Companies own?
Who are Cooper Companies' key executives?
Cooper Companies' management team includes the folowing people:
- Mr. Albert G. White III, Pres, CEO & Director (Age 49)
- Mr. Brian G. Andrews, Sr. VP, CFO & Treasurer (Age 40)
- Mr. Daniel G. McBride, Exec. VP & COO (Age 55)
- Ms. Holly R. Sheffield, Exec. VP & Chief Strategy Officer (Age 48)
- Dr. Robert D. Auerbach, Pres of Coopersurgical Inc (Age 58)
Who are Cooper Companies' major shareholders?
Cooper Companies' stock is owned by a number of of institutional and retail investors. Top institutional investors include BTIM Corp. (0.12%), CWM LLC (0.08%), Handelsinvest Investeringsforvaltning (0.07%), Retirement Systems of Alabama (0.05%), State of Alaska Department of Revenue (0.03%) and Tealwood Asset Management Inc. (0.03%). Company insiders that own Cooper Companies stock include A Thomas Bender, Agostino Ricupati, Allan E Rubenstein, Brian G Andrews, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Paul L Remmell, Randal Golden, Robert D Auerbach, Robert S Weiss and Stanley Md Zinberg. View Institutional Ownership Trends for Cooper Companies.
Which institutional investors are selling Cooper Companies stock?
COO stock was sold by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc., CWM LLC, Handelsinvest Investeringsforvaltning, Huntington National Bank, Tributary Capital Management LLC, Tealwood Asset Management Inc., Bellecapital International Ltd. and State of Alaska Department of Revenue. Company insiders that have sold Cooper Companies company stock in the last year include A Thomas Bender, Agostino Ricupati, Allan E Rubenstein, Brian G Andrews, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Randal Golden, Robert D Auerbach, Robert S Weiss and Stanley Md Zinberg. View Insider Buying and Selling for Cooper Companies.
Which institutional investors are buying Cooper Companies stock?
COO stock was acquired by a variety of institutional investors in the last quarter, including Sciencast Management LP, BTIM Corp., Mercer Global Advisors Inc. ADV, Virtu Financial LLC, We Are One Seven LLC, Brookstone Capital Management, First Manhattan Co. and Conning Inc.. View Insider Buying and Selling for Cooper Companies.
How do I buy shares of Cooper Companies?
Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cooper Companies' stock price today?
One share of COO stock can currently be purchased for approximately $286.74.
How big of a company is Cooper Companies?
Cooper Companies has a market capitalization of $14.16 billion and generates $2.53 billion in revenue each year. The medical device company earns $139.90 million in net income (profit) each year or $11.50 on an earnings per share basis. Cooper Companies employs 12,000 workers across the globe.
What is Cooper Companies' official website?
How can I contact Cooper Companies?
Cooper Companies' mailing address is 6140 Stoneridge Mall Road Suite 590, PLEASANTON CA, 94588. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected]
MarketBeat Community Rating for Cooper Companies (NYSE COO)
MarketBeat's community ratings are surveys of what our community members think about Cooper Companies and other stocks. Vote "Outperform" if you believe COO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COO will underperform the S&P 500 over the long term. You may vote once every thirty days.
